Loading...
Loading...
Among the 4 tracked institutional investors we monitor, GYRE (GYRE THERAPEUTICS INC) is held with a combined value of $15.41M across 2,195,262 shares. The largest holder is VANGUARD GROUP INC with a position worth $8.48M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings.
Total Institutional Value
$15.41M
Total Shares Held
2,195,262
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $8.48M | 0.00% | New |
| 2 | BlackRock, Inc. | $5.29M | 0.00% | +5.3% |
| 3 | STATE STREET CORP | $1.51M | 0.00% | +7.0% |
| 4 | FMR LLC | $130.46K | 0.00% | +81.6% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of GYRE with a position worth $8.48M, representing 0.00% of their portfolio. In total, 4 institutional investors hold GYRE with a combined value of $15.41M.
In the most recent quarter, 1 fund opened a new position in GYRE. Additionally, 3 increased their holdings.
Institutional investors hold $15.41M worth of GYRE stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $8.48M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GYRE, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GYRE positions.